A comprehensive outlook on intracerebral therapy of malignant gliomas.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Critical reviews in oncology/hematology

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.critrevonc.2010.09.001PMID 20888252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Image-guided convection-enhanced delivery platform in the treatment of neurological diseases

  2011cited by this paper
• Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1

  2010cited by this paper
• Poor drug distribution as a possible explanation for the results of the PRECISE trial.

  2010cited by this paper
• Localized BCNU chemotherapy and the multimodal management of malignant glioma

  2009cited by this paper
• Convection-enhanced delivery of nanocarriers for the treatment of brain tumors.

  2009cited by this paper
• Novel drug delivery strategies in neuro-oncology

  2009cited by this paper
• Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.

  2009cited by this paper
• Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme

  2009cited by this paper
• Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.

  2008cited by this paper
• Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

  2008cited by this paper
• Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?

  2008cited by this paper
• Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas

  2008cited by this paper
• Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

  2008cited by this paper
• Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery.

  2008cited by this paper
• A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.

  2008cited by this paper
• EFFECTS OF DRUG EFFLUX ON CONVECTION‐ENHANCED PACLITAXEL DELIVERY TO MALIGNANT GLIOMAS: TECHNICAL NOTE

  2007cited by this paper
• Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

  2007cited by this paper
• Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note.

  2007cited by this paper
• Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.

  2007cited by this paper
• Clinical Experience with α-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

  2007cited by this paper
• Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.

  2007cited by this paper
• INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION‐ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS: DESCRIPTIVE EFFECTS OF TARGET ANATOMY AND CATHETER POSITIONING

  2007cited by this paper
• Convection-enhanced delivery of therapeutics for brain disease, and its optimization.

  2006cited by this paper
• Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results.

  2006cited by this paper
• New Methods for Direct Delivery of Chemotherapy for Treating Brain Tumors

  2006cited by this paper
• Local Targeting of Malignant Gliomas by the Diffusible Peptidic Vector 1,4,7,10-Tetraazacyclododecane-1-Glutaric Acid-4,7,10-Triacetic Acid-Substance P

  2006cited by this paper
• Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

  2006cited by this paper
• Surgifoam and Mitoxantrone in the Glioblastoma Multiforme Postresection Cavity: The First Step of Locoregional Chemotherapy through an Ad Hoc-placed Catheter: Technical Note

  2006cited by this paper
• Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.

  2005cited by this paper
• Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma

  2005cited by this paper
• O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma

  2005cited by this paper
• Role of polyanhydrides as localized drug carriers.

  2005cited by this paper
• Safety and Feasibility of Convection-enhanced Delivery of Cotara for the Treatment of Malignant Glioma: Initial Experience in 51 Patients

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Local and Sustained Delivery of 5-Fluorouracil from Biodegradable Microspheres for the Radiosensitization of Malignant Glioma: A Randomized Phase II Trial

  2005cited by this paper
• Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

  2004cited by this paper
• Human central nervous system and plasma pharmacology of mitoxantrone

  2004cited by this paper
• A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

  2003cited by this paper
• Combined-modality Treatment of Leptomeningeal Gliomatosis

  2003cited by this paper
• Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

  2003cited by this paper
• New approach in delivering chemotherapy: locoregional treatment for recurrent glioblastoma (rGBM).

  2003cited by this paper
• Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma

  2003cited by this paper
• Drug delivery to the central nervous system: a review.

  2003cited by this paper
• Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas

  2003cited by this paper
• Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres.

  2002cited by this paper
• A Phase I Trial of Continuously Infused Intratumoral Bleomycin for the Treatment of Recurrent Glioblastoma Multiforme

  2002cited by this paper
• Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

  2002cited by this paper
• Intratumoral Doxorubicin in Patients With Malignant Brain Gliomas

  2002cited by this paper
• Local Chemotherapy with Cisplatin-depot for Glioblastoma Multiforme

  2002cited by this paper
• Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach

  2000cited by this paper
• The role of interstitial BCNU chemotherapy in the treatment of malignant glioma.

  2000cited by this paper
• A comparison of treatment results for recurrent malignant gliomas.

  2000cited by this paper
• Reservoir systems for intraventricular chemotherapy

  1998cited by this paper
• Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

  1997cited by this paper
• Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors

  1997cited by this paper
• Intratumoral chemotherapy. Commentaries

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.

  1995cited by this paper
• Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain.

  1995cited by this paper
• Intratumoral chemotherapy.

  1995cited by this paper
• Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

  1995cited by this paper
• Convection-enhanced delivery of macromolecules in the brain.

  1994cited by this paper
• Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.

  1994cited by this paper
• Biocompatibility of a Biodegradable, Controlled-Release Polymer in the Rabbit Brain

  1989cited by this paper
• Assumptions in the radiotherapy of glioblastoma

  1980cited by this paper

• Gastrin-Releasing Peptide Receptor Targeting PET/CT With 68Ga-NOTA-RM26 in the Assessment of Glioma and Combined Multiregional Biopsies

  2025cites this paper
• FOSL1-PRMT1 transcriptional-epigenetic circuit promotes glioblastoma radioresistance via calcyphosine-mediated DNA repair and invasion

  2025cites this paper
• Implantable systems for neurological chronotherapy.

  2025cites this paper
• CAR T cell therapy for central nervous system solid tumors: current progress and future directions

  2025cites this paper
• Harnessing immunotherapy: cancer vaccines as novel therapeutic strategies for brain tumor

  2025cites this paper
• Nanoparticle delivery for central nervous system diseases and its clinical application

  2024cites this paper
• Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: between chemoattraction and tumor shaping into resection cavities.

  2023cites this paper
• A Biphasic Fluid-Structure Interaction Model of Backflow During Infusion Into Agarose Gel.

  2023cites this paper
• Biological functions and therapeutic potential of SHCBP1 in human cancer.

  2023cites this paper
• Overcoming the blood-brain barrier as a factor for increasing the efficiency of drug therapy for glioblastoma

  2023cites this paper
• Infusion of Therapeutic Agents to the Brain (Convection-Enhanced Intraparenchymal Delivery)

  2022cites this paper
• LncRNA PART1 inhibits glioma proliferation and migration via miR-374b/SALL1 axis.

  2022cites this paper
• Nanomedicine approaches for medulloblastoma therapy

  2022cites this paper
• Long non‑coding RNA PART1: dual role in cancer

  2022cites this paper
• Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems

  2021cites this paper
• Bypassing the Blood-Brain Barrier to Treat Brain Cancer: A Systematic Review of the Efficacy of Carmustine Wafer Implant Therapy

  2021cites this paper
• Multiparametric magnetic resonance imaging features of a canine glioblastoma model

  2021cites this paper
• Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas

  2020cites this paper
• Current Status of Glioblastoma Treatment

  2020cites this paper
• Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig

  2020cites this paper
• PART1 and hsa-miR-429-Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients

  2020cites this paper
• Lentiviral Vector Induced Modeling of High-Grade Spinal Cord Glioma in Minipigs

  2020cites this paper
• Immunological aspects of intratumoral chemotherapy and immunotherapy in malignant brain tumors

  2020cites this paper
• PEAMOtecan, a novel chronotherapeutic polymeric drug for brain cancer.

  2020cites this paper
• Contributions of Drug Transporters to Blood-Brain Barriers.

  2019cites this paper
• Biomaterials for local drug delivery in central nervous system

  2019cites this paper
• Convection-Enhanced Intraparenchymal Delivery of Drugs to the Brain

  2019cites this paper
• Drug delivery to the brain

  2019cites this paper
• Malignant Intracranial High Grade Glioma and Current Treatment Strategy.

  2019cites this paper
• Ubiquitin ligase RNF5 serves an important role in the development of human glioma

  2019cites this paper
• Targeted Local Therapy for Management of Intracranial High-Grade Gliomas.

  2018cites this paper
• PPARα Regulates the Proliferation of Human Glioma Cells through miR-214 and E2F2

  2018cites this paper
• Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma

  2018cites this paper
• Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

  2018cites this paper
• Development of induced glioblastoma by implantation of a human xenograft in Yucatan minipig as a large animal model.

  2017cites this paper
• miR‑218 inhibits the proliferation of human glioma cells through downregulation of Yin Yang 1.

  2017cites this paper
• β-transducin repeat-containing E3 ubiquitin protein ligase inhibits migration, invasion and proliferation of glioma cells.

  2017cites this paper
• Targeted antitumor therapy mediated by prodrug-activating mesenchymal stromal cells.

  2017cites this paper
• Developing Epithelial Membrane Protein 2 as a Prognostic Marker for Glioblastoma Treatment Response and Outcomes: Study Proposal and Design

  2017cites this paper
• PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSK3β/β-catenin signaling pathway

  2017cites this paper
• Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors

  2017cites this paper
• Fibronectin-adherent peripheral blood derived mononuclear cells as Paclitaxel carriers for glioblastoma treatment: An in vitro study.

  2017cites this paper
• Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway

  2016cites this paper
• Drug encapsulated aerosolized microspheres as a biodegradable, intelligent glioma therapy.

  2016cites this paper
• Novel chemotherapeutics and other therapies for treating high-grade glioma

  2015cites this paper
• Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

  2015cites this paper
• Drug encapsulated polymeric microspheres for intracranial tumor therapy: A review of the literature.

  2015cites this paper
• Tumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal stem cells for glioma therapy.

  2015cites this paper
• Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1‐mediated ErbB3 ubiquitination and degradation

  2015cites this paper
• Expression of β-transducin repeat-containing E3 ubiquitin protein ligase in human glioma and its correlation with prognosis.

  2015cites this paper
• RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.

  2015cites this paper
• Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

  2015cites this paper
• β-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2.

  2015cites this paper
• Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.

  2014cites this paper
• Recent advances in micro/nanoscale biomedical implants.

  2014cites this paper
• Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing

  2014cites this paper
• Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.

  2014cites this paper
• Diaphanous-Related Formin Hyperactivation is Superior to its Inactivation as an Anti- Invasive Strategy for Glioblastoma

  2014influential citation
• WITHAFERIN A: A NOVEL THERAPEUTIC APPROACH FOR MALIGANT BRAIN TUMORS

  2014cites this paper
• Diphtheria toxin-based targeted toxins that target glioblastoma multiforme

  2014cites this paper
• IDH1 overexpression induced chemotherapy resistance and IDH1 mutation enhanced chemotherapy sensitivity in Glioma cells in vitro and in vivo.

  2014cites this paper
• Identification Of Novel Anti-Brain Tumor-Initiating Cell Compounds Using High-Throughput Screening

  2014cites this paper
• Lower expression of Nrdp1 in human glioma contributes tumor progression by reducing apoptosis

  2014cites this paper
• Polymeric Materials in Drug Delivery

  2014cites this paper
• CacyBP/SIP protein is important for the proliferation of human glioma cells

  2014cites this paper
• Epithelial Membrane Protein-2 (EMP2) Activates Src Protein and Is a Novel Therapeutic Target for Glioblastoma*

  2014cites this paper
• Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults.

  2014cites this paper
• Enhancing the immune response through next generation polymeric vaccine adjuvants

  2014cites this paper
• Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.

  2014cites this paper
• β-elemene Induces Caspase-Dependent Apoptosis in Human Glioma Cells in Vitro-Changes in Bax, Fas/FasL and Bcl-2

  2014cites this paper
• The treatment of glioblastomas: a systematic update on clinical Phase III trials.

  2013cites this paper
• Viral and Non-Viral Gene Therapy for Glioblastoma: New Insights into theTreatment of Malignant Brain Tumors

  2013cites this paper
• maging and histological characterization of a human brain xenograft n pig : The first induced glioma model in a large animal

  2013cites this paper
• Sustainable release of carmustine from biodegradable poly[(d,l)-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies

  2013cites this paper
• Which drug or drug delivery system can change clinical practice for brain tumor therapy?

  2013cites this paper
• The role of Gliadel wafers in the treatment of high-grade gliomas

  2013cites this paper
• Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion

  2013cites this paper
• ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation

  2013cites this paper
• Diphtheria toxin-based targeted toxin therapy for brain tumors

  2013cites this paper
• Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations.

  2012cites this paper
• FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling

  2012cites this paper
• IMPROVING DELIVERY OF ELACRIDAR TO ENHANCE EFFICACY OF MOLECULARLY-TARGETED AGENTS IN TREATMENT OF GLIOBLASTOMA

  2012cites this paper
• Glioblastoma: therapeutic challenges, what lies ahead.

  2012cites this paper
• Multi-Analyte Network Markers for Tumor Prognosis

  2012cites this paper
• Convection-enhanced delivery: from mechanisms to clinical drug delivery for diseases of the central nervous system.

  2012cites this paper
• Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide

  2012cites this paper
• Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells

  2012cites this paper
• The 70th Annual Meeting Special Topics — Part II: Multidisciplinary Treatment for High Grade Gliomas Convection-Enhanced Delivery: From Mechanisms to Clinical Drug Delivery for Diseases of the Central Nervous System

  2012cites this paper
• Pioneering Preclinical Research in Diffuse Intrinsic Pontine Glioma: Towards New Treatment Strategies

  2012cites this paper
• Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

  2012cites this paper
• Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.

  2011cites this paper
• Efficacy of interstitial continuous vincristine infusion in a bioluminescent rodent intracranial tumor model

  2011cites this paper
• Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.

  2011cites this paper
• Strategies in Glioma-Surgery

  2011cites this paper
• Primary brain tumours in adults.

  2003cites this paper
• IDH 1 Overexpression Induced Chemotherapy Resistance and IDH 1 Mutation Enhanced Chemotherapy Sensitivity in Glioma Cells in Vitro and in Vivo

  year unknowncites this paper